Medical Marijuana, Inc. Representatives to Speak and Help Lobby Congress at Conference Focused on Medical Cannabis Policy and Safe Access Globally
SAN DIEGO, April 4, 2017 /PRNewswire/ — Medical Marijuana, Inc. ( MJNA ), the first publicly traded cannabis company in the United States, is pleased to announce that the Company is sponsoring the 5th Annual National Medical Cannabis Unity Conference, where executives will participate with other experts and scientists on panels focusing on new developments in medical cannabis research.
The 5th Annual National Medical Cannabis Unity Conference, taking place in Washington, D.C. from April 7-11, 2017, will focus on the creation of common-sense policies and approaches to safe medical cannabis access and use.
Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus will participate on an “Exciting Developments in Cannabis Research & Access” panel on Saturday, April 8, at 11:00 a.m., to discuss recent breakthroughs in medical cannabis research. In addition, hemp industry icon and first-ever EU Cannabis Cup organizer Dion Markgraaff will participate on a “Global Medical Cannabis Policy & Lessons Learned” panel on Sunday, April 9, at 9:00 a.m. and the CEO of Medical Marijuana, Inc.’s public relations firm CMW Media, Andrew Hard, will participate in a “CBD-Only States” workshop on Monday, April 10, at 4:00 p.m.
“We are proud to be on the forefront of innovations in natural, botanical cannabidiol (CBD) products that are improving the lives of people worldwide,” said Dr. Titus. “Unity 2017 is a fantastic opportunity for industry leaders to exchange ideas and bring attention to the need for and protection of policies that can save lives.”
“By attending this Conference, participants are also given the ability to change history by making an impact on how their legislative representatives view medical cannabis,” said Steph Sherer, Executive Director of Americans for Safe Access. “On Tuesday, attendees are given the chance to meet with members of Congress about federal comprehensive legislation. This is a rare opportunity to have their voices be heard by decision-makers that affect their ability to access safe medical cannabis.”
Markgraaff’s panel will include discussion on the latest efforts globally to access medical cannabis, in which he will discuss Mexico’s changing policy on medical marijuana and how Medical Marijuana, Inc.’s THC-free Real Scientific Hemp Oil-X™ (RSHO-X™) became the first-ever cannabis product to receive approval from the federal government of Mexico for importation. Meanwhile, Hard of CMW Media’s workshop will focus on what comes next in states where CBD oil is legal, but not other types of medical cannabis.
Additionally, Medical Marijuana, Inc. will have a booth at the event where you can get information about their products, including their Real Scientific Hemp Oil™ product line, and speak to industry executives about the benefits of CBD.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
FORWARD-LOOKING DISCLAIMER AND DISCLOSURES
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
The statements in this press release have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.
Public Relations Contact:
Chief Executive Officer
P: 888-829- 0070